EU Medicines Agency @EMA_News@respublicae.eu

RT by @EMA_News: ICYMI: #ConversationsOnCancer for #WorldCancerDay with @EMA_News and patients & investigators. Learn about therapies transforming care for patients with CML, multiple myeloma & melanoma.
Watch: https://www.youtube.com/watch?v=7IWz_xhm194

#GlobalCancerMoonshot

🐦🔗: https://nitter.cz/FDAOncology/status/1757417619626381638#m

[2024-02-13 14:53 UTC]

The consultation on the concept paper on human
https://nitter.cz/search?q=%23phage
therapies will be open until 31 March.
Have your say in the first EMA guideline on these medicines, that could help us fight
https://nitter.cz/search?q=%23antibioticresistance
and open up new routes to treating infections. 👇
https://www.ema.europa.eu/en/development-and-manufacture-human-medicinal-products-specifically-designed-phage-therapy-scientific-guideline#ema-inpage-item-64733

🐦🔗: https://nitter.cz/EMA_News/status/1756936175082704897#m

[2024-02-12 07:00 UTC]

At its February meeting, EMA's
https://nitter.cz/search?q=%23safety
committee reminded healthcare professionals of the risk of serious adverse reactions with the COVID-19 therapeutic Paxlovid, when taken together with certain immunosuppressants.
👉
https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-5-8-february-2024
https://nitter.cz/search?q=%23SafetyOfMedicines
https://nitter.cz/search?q=%23PRAC

🐦🔗: https://nitter.cz/EMA_News/status/1755929090509426959#m

[2024-02-09 12:18 UTC]

Interested in joining our pilot for academic 🎓 and not-for-profit developers of advanced therapy medicines?
EMA has already accepted 3⃣ developers who are receiving enhanced support. 2⃣ additional places are available.
Find out more to apply ⬇️
https://www.ema.europa.eu/en/news/progress-update-pilot-academic-non-profit-developers-advanced-therapy-medicines

🐦🔗: https://nitter.cz/EMA_News/status/1755616411576393924#m

[2024-02-08 15:35 UTC]

Don't forget to register for the EMA/
https://nitter.cz/EORTC
workshop exploring how patient reports on their own health and quality of life can inform regulatory decisions on
https://nitter.cz/search?q=%23cancertreatments
🔗
https://europa.eu/!TVfryM
💻16 Feb - registration deadline

🐦🔗: https://nitter.cz/EMA_News/status/1754873653546701080#m

[2024-02-06 14:24 UTC]

RT by @EMA_News: Happening Now! Conversations on Cancer for #WorldCancerDay with @EMA_News and patients & investigators. Learn about therapies transforming care for patients with CML, multiple myeloma & melanoma.
https://www.youtube.com/watch?v=7IWz_xhm194

#GlobalCancerMoonshot

🐦🔗: https://nitter.cz/FDAOncology/status/1753063584240738378#m

[2024-02-01 14:31 UTC]

RT by @EMA_News: Thank you to the ACT-EU team at the @EMA_News for the amazing workshop last week. Bringing the community together to explore use cases for #ClinicalTrial data analytics using CTIS & EUDRACT illustrates how forward-thinking, collaborative & #PatientCentric EMA truly is.

🐦🔗: https://nitter.cz/EatrisEric/status/1752674114425200846#m

[2024-01-31 12:44 UTC]

RT by @EMA_News: Save the date for a #ConversationsonCancer with @EMA_News for #WorldCancerDay. A panel of patients, investigators & regulators will dive into the latest therapies transforming care for patients with chronic myeloid leukemia, multiple myeloma, and melanoma. https://www.surveymonkey.com/r/HDNCD2Y

🐦🔗: https://nitter.cz/FDAOncology/status/1751996409094504871#m

[2024-01-29 15:51 UTC]

RT by @EMA_News: Meet Feb 1 #ConversationsOnCancer panelists: Biru Yelak @IMFmyeloma; Jan Geissler @WECANadvocate; Stergios Moschos @UNC; Carolin Pothet @EMA_News; Ellin Berman @mskcancercenter; Frederik Ostman; Edward Laane; & FDA's Vab Kumar, Rea Blakey & Rick Pazdur
https://www.surveymonkey.com/r/HDNCD2Y

🐦🔗: https://nitter.cz/FDAOncology/status/1752001441168793654#m

[2024-01-29 16:11 UTC]

RT by @EMA_News: MPE shared patient perspectives at the ACT EU Clinical Trials Analytics Workshop last week. Thanks to @EMA_News for the opportunity to contribute to improving access and usability of clinical trial data.

@LungCancerEu
@AlfonsoAguaron
#ACTEU #myeloma #ClinicalTrials

🐦🔗: https://nitter.cz/MyelomaEurope/status/1751951541185994904#m

[2024-01-29 12:52 UTC]

The new platform supporting the collection of data by EU/EEA Member States on the sales and use of antimicrobials in animals is now live! 🚀
This is a major European milestone in the fight against
https://nitter.cz/search?q=%23AntibioticResistance
. 🦠👊
https://www.ema.europa.eu/en/news/new-platform-collection-sales-and-use-data-antimicrobials-animals
https://nitter.cz/search?q=%23OneHealth
https://nitter.cz/search?q=%23HealthUnion

🐦🔗: https://nitter.cz/EMA_News/status/1751981890314092754#m

[2024-01-29 14:53 UTC]

We are excited to embark on a new project, as part of
https://nitter.cz/search?q=%23TeamEurope
https://nitter.cz/EU_Partnerships
to support regulatory systems in Africa and the setup of the African Medicines Agency (AMA), together with African, European and global partners
👉
https://www.ema.europa.eu/en/news/ema-support-establishment-african-medicines-agency

🐦🔗: https://nitter.cz/EMA_News/status/1751862745954476400#m

[2024-01-29 07:00 UTC]

📢 EMA's human medicines committee, the
https://nitter.cz/search?q=%23CHMP
, recommended 3⃣ new medicines for approval:
☑️ a medicine to treat urinary infections,
https://nitter.cz/search?q=%23Pneumonia
& bacteria in the bloodstream
☑️ a medicine to treat
https://nitter.cz/search?q=%23Neutropenia
☑️ a medicine to treat
https://nitter.cz/search?q=%23Schizophrenia
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-january-2024

🐦🔗: https://nitter.cz/EMA_News/status/1750857301517332635#m

[2024-01-26 12:24 UTC]

EMA recommended 1⃣4⃣
https://nitter.cz/search?q=%23veterinary
https://nitter.cz/search?q=%23medicines
for marketing authorisation in 2023. 🐾 💊 💉
More than half of these had a new active substance which had never been authorised in the 🇪🇺 before.
Check out our annual veterinary medicines highlights ⬇️

🐦🔗: https://nitter.cz/EMA_News/status/1750440567199162717#m

[2024-01-25 08:48 UTC]

RT by @EMA_News: 1⃣ week to go!

Have you registered for our event to mark #WorldCancerDay yet?
If not, do it fast because today is the last day for in person registration. And if you can’t make it to Brussels, you can follow here on our @EU_Health X account.

#EUCancerPlan #HealthUnion

🐦🔗: https://nitter.cz/EU_Health/status/1750071471953567834#m

[2024-01-24 08:22 UTC]

RT by @EMA_News: Let's fight #CervicalCancer together & save 15 000 lives each year!

Watch our animation about the vaccine protecting from #HPV infection - the main cause of cervical cancer & share it with friends!

Info: https://bit.ly/3u5OMC9

#UnitedInProtection #CervicalCancerAwarenessMonth

🐦🔗: https://nitter.cz/ECDC_EU/status/1749816138165612868#m

[2024-01-23 15:27 UTC]

RT by @EMA_News: Upcoming event: @EMA_News Webinar on Rare World Diseases Day 29th February-Orphan medicines development - ask the European regulator. More info and registration: https://erica-rd.eu/event/ema-webinar-on-rare-world-diseases-day/

🐦🔗: https://nitter.cz/ERICA_RD_EU/status/1749793517470384223#m

[2024-01-23 13:57 UTC]

https://nitter.cz/search?q=%23JustPublished
!
EMA's updated
https://nitter.cz/search?q=%23SME
User Guide helps small & medium sized enterprises navigate the requirements for the development and authorisation of human and veterinary medicines.
Explore our guide and contact the SME Office for assistance.
👉
https://www.ema.europa.eu/en/news/major-update-sme-user-guide

🐦🔗: https://nitter.cz/EMA_News/status/1749802001968582816#m

[2024-01-23 14:31 UTC]

RT by @EMA_News: Join us for a Conversation on Cancer Feb. 1 for World Cancer Day with @EMA_News. The panel of patients, investigators & regulators will discuss new therapies revolutionizing care for patients with chronic myeloid leukemia, multiple myeloma & melanoma. https://www.surveymonkey.com/r/HDNCD2Y

🐦🔗: https://nitter.cz/FDAOncology/status/1747967134162887005#m

[2024-01-18 13:00 UTC]

‼️ EMA will hold its first press briefing of 2024, where we will be discussing key developments in human
https://nitter.cz/search?q=%23medicines
throughout 2023.
It will be broadcast live 🔴 today, 16 Jan, from 14:30 to 15:00 CET.
https://nitter.cz/search?q=%23EMAPresser
👉
https://www.ema.europa.eu/en/events/ema-press-briefing-human-medicines-highlights-2023

🐦🔗: https://nitter.cz/EMA_News/status/1747243954062451128#m

[2024-01-16 13:06 UTC]